Puma Biotechnology, Inc.
PBYI- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001401667
In the last 90 days, Puma Biotechnology, Inc. insiders filed 0 open-market purchases and 5 sales; 160 institutions reported holding it in 13F filings for Q2 2026, worth $313.6M in total; no superinvestor holds it.
Q3 2024 vs. Q2 2024
How the institutions holding Puma Biotechnology, Inc. changed between Q2 2024 and Q3 2024.
All holders in Q3 2024All holders in Q2 2024
| Measure | Q2 2024 | Of which not filed for Q3 2024 | Q3 2024 | Change |
|---|---|---|---|---|
| Holders | 99 | 1 | 100 | +2 |
| Shares | 31.0M | 3.57M | 29.7M | +2.34M (+8.5%) |
| Value | $100.9M | $11.6M | $75.9M | −$13.4M (−15.0%) |
1 institution that held it in Q2 2024 haven't filed for Q3 2024 yet. Not filing isn't selling, so the changes leave them out.
New holders (19)
Institutions that held Puma Biotechnology, Inc. at the end of Q3 2024 but not at the end of Q2 2024.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| BlackRock, Inc. | 3,827,223 | $9.76M | 0.00% |
| Kennedy Capital Management, Inc. | 593,046 | $1.51M | 0.03% |
| Los Angeles Capital Management LLC | 245,695 | $626.5K | 0.00% |
| Advantage Alpha Capital Partners LP | 108,129 | $275.7K | 0.06% |
| D. E. Shaw & Co., Inc. | 57,388 | $146.3K | 0.00% |
| ExodusPoint Capital Management, LP | 30,905 | $79.0K | 0.00% |
| Virtu Financial LLC | 26,509 | $68.0K | 0.00% |
| Mirae Asset Global ETFs Holdings Ltd. | 22,710 | $57.9K | 0.00% |
| Franklin Resources Inc | 15,967 | $45.5K | 0.00% |
| Dynamic Technology Lab Private Ltd | 17,366 | $44.0K | 0.00% |
| SG Americas Securities, LLC | 13,416 | $34.0K | 0.00% |
| Two Sigma Securities, LLC | 12,173 | $31.0K | 0.00% |
| Group One Trading, L.P. | 4,695 | $12.0K | 0.00% |
| GWM Advisors LLC | 4,611 | $11.8K | 0.00% |
| Allspring Global Investments Holdings, LLC | 667 | $1.70K | 0.00% |
| Jaffetilchin Investment Partners, LLC | 400 | $1.02K | 0.00% |
| Nisa Investment Advisors, LLC | 126 | $321 | 0.00% |
| Sterling Capital Management LLC | 100 | $255 | 0.00% |
| Capital Performance Advisors LLP | 15 | $38 | 0.00% |
Sold out (17)
Institutions that held Puma Biotechnology, Inc. at the end of Q2 2024 and filed for Q3 2024 without it.
| Institution | Shares, Q2 2024 | Value, Q2 2024 |
|---|---|---|
| Great Point Partners LLC | 1,486,544 | $4.85M |
| Susquehanna International Group, LLP | 256,263 | $835.4K |
| Marshall Wace, LLP | 200,085 | $652.3K |
| Rice Hall James & Associates, LLC | 144,792 | $472.0K |
| Assenagon Asset Management S.A. | 140,205 | $457.1K |
| Man Group plc | 117,665 | $383.6K |
| Arrowstreet Capital, Limited Partnership | 92,174 | $300.0K |
| Bank of Montreal | 70,352 | $232.2K |
| Alpine Global Management, LLC | 40,116 | $130.8K |
| Trexquant Investment LP | 32,668 | $106.5K |
| Brandywine Global Investment Management, LLC | 32,210 | $105.0K |
| Oxford Asset Management LLP | 21,007 | $68.5K |
| Manufacturers Life Insurance Company, The | 17,765 | $57.9K |
| Marathon Trading Investment Management LLC | 14,236 | $46.4K |
| MetLife Investment Management | 10,973 | $35.8K |
| Simplex Trading, LLC | 3,498 | $11.0K |
| Concord Wealth Partners | 6 | $20 |
Not filed for Q3 2024 yet (1)
Institutions that held Puma Biotechnology, Inc. at the end of Q2 2024 and haven't filed a 13F for Q3 2024. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q2 2024 | Value, Q2 2024 |
|---|---|---|
| BlackRock Inc. | 3,572,806 | $11.6M |